SHARON GOMEZ: Open Payments
NPI 1922309509 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 16 payments from 10 companies in 2025. Trend: 2023 $369 · 2024 $332 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $67 |
| PFIZER INC. | 3 | $59 |
| Novo Nordisk Inc | 2 | $56 |
| Abbott Laboratories | 2 | $40 |
| Dexcom, Inc. | 1 | $39 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: UBRELVY, FREESTYLE LIBRE 3, PREVNAR 20, Dexcom G6 Transmitter, Ozempic, SHINGRIX, AIRSUPRA, TEPEZZA.
Industry payments across PA — which companies pay providers there.
